首页> 美国卫生研究院文献>Annals of Oncology >PD-016Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)

【2h】

PD-016Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)

机译：PD-016对患有晚期DKK1 +食管癌（EC）或胃食管连接瘤（GEJ）的患者（pts）DKN-01联合紫杉醇（P）进行I期研究的最新结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Annals of Oncology
作者
D.P. Ryan; J. Murphy; D. Mahalingam; J. Strickler; S. Stein; C. Sirard; S. Landau; J. Bendell;
展开▼
作者单位

展开▼
年(卷),期 -1(27),Suppl 2
年度 -1
页码 ii108
总页数 1
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-21 10:50:33

相似文献

外文文献
中文文献
专利

1. 6656 Evaluation of sE-Selectin and circulating Vascular Endothelial Growth Factor (VEGF) in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma treated with cetuximab in combination with cisplatin and docetaxel (Italian phase II DOCETUX Study) [J] . V.Mutri, E.Bucca, S.Giaquinta, European Journal of Cancer Supplements . 2009,第2期

机译：6656在西妥昔单抗联合顺铂和多西他赛联合治疗的晚期胃或胃食管连接（GEJ）腺癌患者中评估sE-选择素和循环血管内皮生长因子（意大利II期DOCETUX研究）
2. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer. [J] . Sun Q, Liu C, Zhong H Japanese journal of clinical oncology. . 2009,第4期

机译：每周紫杉醇联合顺铂联合化疗治疗晚期胃癌和胃食管癌的多中心II期试验。
3. Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer [J] . Qing Sun1 Chaoying Liu2 Haijun Zhong3 Baoliang Zhong4 Haiyuan Xu5 Wenxiang Shen5 and Daoyuan Wang6 Japanese Journal of Clinical Oncology . 2009,第4期

机译：每周紫杉醇联合顺铂联合化疗治疗晚期胃癌和胃食管癌的多中心II期试验
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Communication preferences, expectations of benefit, and symptom burdens among advanced cancer patients and partners during patient participation in phase I trials [D] . Hlubocky, Fay J. 2010

机译：患者参加I期试验期间，晚期癌症患者及其伴侣之间的沟通偏好，受益期望以及症状负担
6. Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer [O] . Kyung Won Seo, Taeyong Jeon, Sewon Kim, 2017

机译：晚期/转移性胃癌中人表皮生长因子受体2表达的流行病学研究：胃和胃食管交界处肿瘤组织样品中人表皮生长因子受体2状态的评估
7. Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer [O] . Qing Sun, Chaoying Liu, Haijun Zhong, 2008

机译：紫杉醇加顺铂联合化疗治疗晚期胃癌和胃食管癌的多中心II期临床试验

PD-016Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)

著录项

相似文献

相关主题

期刊订阅